Mirati Therapeutics
|
8.7 |
$811M |
|
3.7M |
219.64 |
Amicus Therapeutics
(FOLD)
|
6.2 |
$580M |
|
25M |
23.09 |
Bridgebio Pharma
(BBIO)
|
5.1 |
$477M |
|
6.7M |
71.11 |
Retrophin Note 2.500% 9/1 (Principal)
|
4.7 |
$443M |
|
45M |
9.83 |
Iovance Biotherapeutics
(IOVA)
|
4.6 |
$425M |
|
9.2M |
46.40 |
Invitae
(NVTAQ)
|
3.3 |
$305M |
|
7.3M |
41.81 |
Springworks Therapeutics
(SWTX)
|
3.3 |
$303M |
|
4.2M |
72.52 |
Global Blood Therapeutics In
|
2.6 |
$246M |
|
5.7M |
43.31 |
Horizon Therapeutics Pub L SHS
|
2.4 |
$226M |
|
3.1M |
73.15 |
Zymeworks
|
2.2 |
$203M |
|
4.3M |
47.26 |
Rocket Pharmaceuticals
(RCKT)
|
2.0 |
$186M |
|
3.4M |
54.84 |
Neurocrine Biosciences
(NBIX)
|
2.0 |
$182M |
|
1.9M |
95.85 |
Collegium Pharmaceutical Note 2.625% 2/1 (Principal)
|
1.9 |
$173M |
|
18M |
9.90 |
Nevro
(NVRO)
|
1.8 |
$169M |
|
978k |
173.10 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
1.8 |
$165M |
|
9.0M |
18.38 |
Outset Med
(OM)
|
1.7 |
$162M |
|
2.8M |
56.84 |
Vbi Vaccines Com New
|
1.6 |
$151M |
|
55M |
2.75 |
Athenex
|
1.6 |
$150M |
|
14M |
11.06 |
Atea Pharmaceuticals
(AVIR)
|
1.4 |
$130M |
|
3.1M |
41.78 |
Novavax Com New
(NVAX)
|
1.2 |
$116M |
|
1.0M |
111.51 |
Frequency Therapeutics
|
1.2 |
$115M |
|
3.3M |
35.26 |
Kodiak Sciences
(KOD)
|
1.2 |
$110M |
|
752k |
146.91 |
Athira Pharma
(ATHA)
|
1.1 |
$107M |
|
3.1M |
34.25 |
Meiragtx Holdings
(MGTX)
|
1.1 |
$105M |
|
6.9M |
15.14 |
C4 Therapeutics Com Stk
(CCCC)
|
1.1 |
$105M |
|
3.2M |
33.13 |
Relay Therapeutics
(RLAY)
|
1.0 |
$97M |
|
2.3M |
41.56 |
Travere Therapeutics
(TVTX)
|
1.0 |
$95M |
|
3.5M |
27.25 |
Eidos Therapeutics
|
1.0 |
$90M |
|
687k |
131.58 |
Albireo Pharma
|
1.0 |
$89M |
|
2.4M |
37.51 |
Quotient SHS
|
0.9 |
$84M |
|
16M |
5.21 |
Kronos Bio
(KRON)
|
0.9 |
$83M |
|
2.8M |
29.87 |
Arrowhead Pharmaceuticals
(ARWR)
|
0.9 |
$82M |
|
1.1M |
76.73 |
Solid Biosciences
|
0.9 |
$82M |
|
11M |
7.58 |
Coherus Biosciences
(CHRS)
|
0.9 |
$81M |
|
4.7M |
17.38 |
Cerevel Therapeutics Hldng I
(CERE)
|
0.8 |
$75M |
|
4.5M |
16.58 |
Provention Bio
|
0.8 |
$72M |
|
4.2M |
16.94 |
Kadmon Hldgs
|
0.7 |
$65M |
|
16M |
4.15 |
Immunovant
(IMVT)
|
0.7 |
$65M |
|
1.4M |
46.19 |
Oncorus
|
0.7 |
$64M |
|
2.0M |
32.33 |
Inari Medical Ord
(NARI)
|
0.6 |
$58M |
|
669k |
87.29 |
Zentalis Pharmaceuticals
(ZNTL)
|
0.6 |
$55M |
|
1.1M |
51.94 |
Pmv Pharmaceuticals
(PMVP)
|
0.6 |
$55M |
|
886k |
61.51 |
Tarsus Pharmaceuticals
(TARS)
|
0.6 |
$54M |
|
1.3M |
41.33 |
Adaptive Biotechnologies Cor
(ADPT)
|
0.6 |
$54M |
|
905k |
59.13 |
Crinetics Pharmaceuticals In
(CRNX)
|
0.6 |
$52M |
|
3.7M |
14.11 |
Urovant Sciences SHS
|
0.5 |
$50M |
|
3.1M |
16.13 |
Compass Pathways Sponsored Ads
(CMPS)
|
0.5 |
$50M |
|
1.0M |
47.64 |
Agile Therapeutics
|
0.5 |
$46M |
|
16M |
2.87 |
Arena Pharmaceuticals Com New
|
0.5 |
$44M |
|
575k |
76.83 |
Forma Therapeutics Hldgs SHS
|
0.5 |
$44M |
|
1.3M |
34.90 |
Aldeyra Therapeutics
(ALDX)
|
0.5 |
$43M |
|
6.3M |
6.86 |
Stoke Therapeutics
(STOK)
|
0.4 |
$42M |
|
672k |
61.93 |
Collegium Pharmaceutical Inc Common Stock Usd
(COLL)
|
0.4 |
$41M |
|
2.1M |
20.03 |
Verrica Pharmaceuticals
(VRCA)
|
0.4 |
$39M |
|
3.4M |
11.51 |
Sage Therapeutics
(SAGE)
|
0.4 |
$38M |
|
440k |
86.51 |
Lyra Therapeutics
(LYRA)
|
0.4 |
$37M |
|
3.2M |
11.40 |
Vyne Therapeutics Com New
|
0.4 |
$36M |
|
23M |
1.58 |
Cogent Biosciences
(COGT)
|
0.4 |
$36M |
|
3.2M |
11.23 |
Neptune Wellness Solutions I
|
0.4 |
$35M |
|
22M |
1.56 |
Adma Biologics
(ADMA)
|
0.3 |
$32M |
|
17M |
1.95 |
Avidity Biosciences Ord
(RNA)
|
0.3 |
$32M |
|
1.2M |
25.52 |
Rapt Therapeutics
(RAPT)
|
0.3 |
$31M |
|
1.6M |
19.75 |
Iveric Bio
|
0.3 |
$31M |
|
4.5M |
6.91 |
Silk Road Medical Inc Common
(SILK)
|
0.3 |
$29M |
|
465k |
62.98 |
Allogene Therapeutics
(ALLO)
|
0.3 |
$29M |
|
1.1M |
25.24 |
Macrogenics
(MGNX)
|
0.3 |
$29M |
|
1.3M |
22.86 |
Spdr Ser Tr S&p Biotech Put Option
(XBI)
|
0.3 |
$28M |
|
200k |
140.78 |
Female Health
(VERU)
|
0.3 |
$28M |
|
3.3M |
8.65 |
Accolade
(ACCD)
|
0.3 |
$27M |
|
627k |
43.50 |
Concert Pharmaceuticals I equity
|
0.3 |
$27M |
|
2.2M |
12.64 |
Immatics SHS
(IMTX)
|
0.3 |
$27M |
|
2.5M |
10.79 |
Regeneron Pharmaceuticals
(REGN)
|
0.3 |
$27M |
|
55k |
483.12 |
Pulmonx Corp
(LUNG)
|
0.3 |
$27M |
|
385k |
69.02 |
Fusion Pharmaceuticals
(FUSN)
|
0.3 |
$26M |
|
2.2M |
11.75 |
Establishment Labs Holdings Ord
(ESTA)
|
0.3 |
$26M |
|
697k |
37.64 |
Anaptysbio Inc Common
(ANAB)
|
0.3 |
$26M |
|
1.2M |
21.50 |
4d Molecular Therapeutics In
(FDMT)
|
0.3 |
$25M |
|
600k |
41.45 |
1life Healthcare
|
0.2 |
$23M |
|
520k |
43.65 |
Nanostring Technologies
(NSTGQ)
|
0.2 |
$23M |
|
338k |
66.88 |
Vaxcyte
(PCVX)
|
0.2 |
$23M |
|
850k |
26.57 |
Geron Corporation
(GERN)
|
0.2 |
$21M |
|
14M |
1.59 |
Therapeutics Acquisition Cor Com Cl A
|
0.2 |
$21M |
|
1.5M |
13.92 |
Amyris Com New
(AMRSQ)
|
0.2 |
$21M |
|
3.3M |
6.17 |
Verona Pharma Sponsored Ads
(VRNA)
|
0.2 |
$20M |
|
2.9M |
7.00 |
Wave Life Sciences SHS
(WVE)
|
0.2 |
$20M |
|
2.5M |
7.87 |
Leap Therapeutics
|
0.2 |
$19M |
|
8.5M |
2.25 |
Viatris
(VTRS)
|
0.2 |
$19M |
|
1.0M |
18.74 |
Repligen Corporation
(RGEN)
|
0.2 |
$19M |
|
98k |
191.63 |
Scynexis Com New
(SCYX)
|
0.2 |
$18M |
|
2.4M |
7.65 |
Harmony Biosciences Hldgs In
(HRMY)
|
0.2 |
$18M |
|
503k |
36.15 |
Nanobiotix Sa Sponsored Ads
(NBTX)
|
0.2 |
$18M |
|
1.1M |
16.50 |
Dicerna Pharmaceuticals
|
0.2 |
$18M |
|
800k |
22.03 |
Dbv Technologies S A Sponsored Adr
(DBVT)
|
0.2 |
$17M |
|
6.6M |
2.62 |
Cytomx Therapeutics
(CTMX)
|
0.2 |
$17M |
|
2.6M |
6.55 |
Morphic Hldg
(MORF)
|
0.2 |
$16M |
|
487k |
33.55 |
Longview Acquisition Corp Unit 99/99/9999
|
0.2 |
$15M |
|
700k |
21.65 |
Protara Therapeutics Com Stk
(TARA)
|
0.2 |
$15M |
|
609k |
24.21 |
American Well Corp Cl A
(AMWL)
|
0.1 |
$13M |
|
525k |
25.33 |
Vaneck Vectors Etf Tr Pharmaceutical Put Option
(PPH)
|
0.1 |
$13M |
|
200k |
66.47 |
Forte Biosciences
(FBRX)
|
0.1 |
$13M |
|
350k |
36.41 |
Taysha Gene Therapies Com Shs
(TSHA)
|
0.1 |
$13M |
|
470k |
26.54 |
Tcr2 Therapeutics Inc cs
|
0.1 |
$12M |
|
400k |
30.93 |
Health Catalyst
(HCAT)
|
0.1 |
$12M |
|
276k |
43.53 |
Bcls Acquisition Corp Com Cl A
|
0.1 |
$11M |
|
1.0M |
11.14 |
Sc Health Corp Unit 99/99/9999
|
0.1 |
$11M |
|
1.0M |
10.99 |
Curis Com New
|
0.1 |
$10M |
|
1.3M |
8.19 |
Maravai Lifesciences Hldgs I Com La A
(MRVI)
|
0.1 |
$9.8M |
|
350k |
28.05 |
Viewray
(VRAYQ)
|
0.1 |
$9.4M |
|
2.5M |
3.82 |
Revolution Medicines
(RVMD)
|
0.1 |
$8.9M |
|
224k |
39.59 |
Poseida Therapeutics I
(PSTX)
|
0.1 |
$8.6M |
|
788k |
10.97 |
Dyne Therapeutics
(DYN)
|
0.1 |
$8.4M |
|
400k |
21.00 |
Sotera Health
(SHC)
|
0.1 |
$8.2M |
|
300k |
27.44 |
Aquestive Therapeutics
(AQST)
|
0.1 |
$7.4M |
|
1.4M |
5.35 |
Syndax Pharmaceuticals
(SNDX)
|
0.1 |
$6.7M |
|
300k |
22.24 |
Vincera Pharma
(VINC)
|
0.1 |
$6.3M |
|
300k |
20.91 |
Sigilon Therapeutics
|
0.1 |
$6.0M |
|
125k |
48.03 |
Health Sciences Acq Corp 2 Ord Shs
|
0.1 |
$5.8M |
|
450k |
12.81 |
Bctg Acquisition Corp
|
0.1 |
$5.7M |
|
500k |
11.44 |
Phreesia
(PHR)
|
0.1 |
$5.4M |
|
100k |
54.26 |
Consonance Hfw Acquisition C Unit 99/99/9999
|
0.1 |
$5.2M |
|
500k |
10.47 |
Deerfield Healthcare Tech Ac Unit 07/16/2025
|
0.0 |
$4.5M |
|
300k |
15.00 |
908 Devices
(MASS)
|
0.0 |
$4.4M |
|
78k |
56.95 |
Anavex Life Sciences Corp Com New
(AVXL)
|
0.0 |
$4.2M |
|
780k |
5.40 |
Protagonist Therapeutics
(PTGX)
|
0.0 |
$4.1M |
|
204k |
20.16 |
Motus Gi Hldgs Incorporated
|
0.0 |
$3.9M |
|
4.2M |
0.93 |
Molecular Templates
|
0.0 |
$3.9M |
|
412k |
9.39 |
Burning Rock Biotech Sponsored Ads
(BNR)
|
0.0 |
$3.5M |
|
150k |
23.10 |
Galera Therapeutics
(GRTX)
|
0.0 |
$3.3M |
|
325k |
10.23 |
Lifesci Acquisition Ii Corp
|
0.0 |
$3.2M |
|
300k |
10.67 |
Adaptimmune Therapeutics Sponds Adr
(ADAP)
|
0.0 |
$2.2M |
|
400k |
5.39 |
Eiger Biopharmaceuticals
|
0.0 |
$1.7M |
|
140k |
12.29 |
Ferrari Nv Ord
(RACE)
|
0.0 |
$1.4M |
|
6.2k |
229.52 |
Sierra Oncology Com New
|
0.0 |
$1.1M |
|
67k |
16.02 |
Vincera Pharma *w Exp 12/24/202
|
0.0 |
$990k |
|
300k |
3.30 |
Abcellera Biologics
(ABCL)
|
0.0 |
$805k |
|
20k |
40.25 |
Legend Biotech Corp Sponsored Ads
(LEGN)
|
0.0 |
$704k |
|
25k |
28.16 |
Social Capital Hedosophia Hld Shs Cl A
|
0.0 |
$671k |
|
40k |
16.77 |
Deerfield Healthcare Tech Ac Com Cl A
|
0.0 |
$312k |
|
20k |
15.60 |
Outlook Therapeutics *w Exp 02/18/202
|
0.0 |
$93k |
|
421k |
0.22 |